Xiangyu Medical Hits Day Low at CNY 51.03 Amid Price Pressure

Xiangyu Medical Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 5.03% on May 29, 2026. The stock reached an intraday low of CNY 51.03, reflecting a challenging trading environment. Over the past week, Xiangyu Medical has seen a significant downturn of 9.36%, and its performance over the last month has also been negative, with a decrease of 11.13%. Year-to-date, the stock has declined by 15.04%, contrasting sharply with the China Shanghai Composite, which has gained 2.51% during the same period. Despite a strong annual return of 37.07% over the past year, the company has faced difficulties, including a substantial drop in profits by 54.8%. Key financial metrics indicate a low operating cash flow of CNY 155.86 million and a return on equity of 3.71%. The stock's price-to-book ratio stands at 46.61, suggesting a high valuation relative to its book value. These factors contribute to the current market dynamics surrounding Xiangyu Medical Co.